Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - GREEN VISION BIOTECHNOLOGY CORP. | gvbt_ex322.htm |
| EX-31.2 - EX-31.2 - GREEN VISION BIOTECHNOLOGY CORP. | gvbt_ex312.htm |
| EX-31.1 - EX-31.1 - GREEN VISION BIOTECHNOLOGY CORP. | gvbt_ex311.htm |
| 10-K - FORM 10-K - GREEN VISION BIOTECHNOLOGY CORP. | gvbt_10q.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), I, Lam Ching Wan, William, certify that:
| 1. | The Annual Report of Green Vision Biotechnology Corp. (the “Company”) on Form 10-K for the year ended December 31, 2020 (the “Report”), as filed with the Securities and Exchange Commission as of the date hereof, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: September 21, 2021 |
| /s/ Lam Ching Wan, William |
|
|
|
| Lam Ching Wan, William |
|
|
|
| Chief Executive Officer of |
|
This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
A signed original of this written statement required by Section 906 has been provided to Green Vision Biotechnology Corp. and will be retained by Green Vision Biotechnology Corp. and f